56850-59-0

Basic information

• Product Name: 3-BENZYLOXY-2-METHYL-1-PROPANOL
• Synonyms: RARECHEM AH CK 0035;3-BENZYLOXY-2-METHYL-1-PROPANOL;3-BENZYLOXY-2-METHYLPROPAN-1-OL;3-BENZYLOXY-2-METHYL-1-PROPANOL >97%;rac 3-Benzyloxy-2-methyl-1-propanol, 97%
• CAS NO: 56850-59-0
• Molecular Formula: C₁₁H₁₆O₂
• Molecular Weight: 180.24
• Mol File: 56850-59-0.mol
• Article Data: 23

Chemical Properties

• Boiling Point: 298.5 °C at 760 mmHg
• Flash Point: 126.5 °C
• Appearance: /
• Density: 1.023 g/cm³
• Vapor Pressure: 0.000565mmHg at 25°C
• Refractive Index: 1.513
• CAS DataBase Reference: 3-BENZYLOXY-2-METHYL-1-PROPANOL(CAS DataBase Reference)
• NIST Chemistry Reference: 3-BENZYLOXY-2-METHYL-1-PROPANOL(56850-59-0)
• EPA Substance Registry System: 3-BENZYLOXY-2-METHYL-1-PROPANOL(56850-59-0)

Safety Data

• Hazard Codes: Xi
• Statements: 36/37/38
• Safety Statements: 26-36/37/39
• Hazardous Substances Data: 56850-59-0(Hazardous Substances Data)

Usage

General Description

3-BENZYLOXY-2-METHYL-1-PROPANOL, also known as benzyl alcohol and isobutanol, is an organic compound that consists of a benzyl group and a hydroxy group attached to a propanol chain. It is commonly used as a solvent and as a precursor in the synthesis of various pharmaceuticals and fragrance products. This chemical has a mild, pleasant odor and is often utilized in the production of perfumes and flavorings. Additionally, it has antimicrobial and antifungal properties, making it a common ingredient in personal care products and disinfectants. Its ability to dissolve a wide range of substances also makes it useful in the cosmetic and pharmaceutical industries for formulating various products.

InChI:InChI=1/C11H16O2/c1-10(7-12)8-13-9-11-5-3-2-4-6-11/h2-6,10,12H,7-9H2,1H3

Upstream product

• 5658-46-8 ((2-methylallyloxy)methyl)benzene 
• 91796-44-0 Benzyl 3-(phenylmethoxy)-2-methylpropanoate 
• 2163-42-0 2-methyl-1.3-propanediol 
• 100-39-0 benzyl bromide 
• 124755-27-7 (E)-(2R,5R,6S)-7-<(tert-butyldimethylsilyl)oxy>-2,4,6-trimethyl-3-heptene-1,5-diol 
• 3587-60-8 Benzyloxymethyl chloride 
• 191105-59-6 (S)-N-propionyl-4-(4-hydroxybenzyl)oxazolidin-2-one 
• 27942-89-8 5-methyl-2-phenyl-[1,3]dioxane 
• 100-52-7 benzaldehyde 
• 59965-24-1 (+/-)-methyl 2-methyl-3-(phenylmethoxy)propanoate 
• 126309-00-0 4-(3-Benzyloxy-2-methyl-propoxymethyl)-1,5-dimethoxy-naphthalene 
• 126308-98-3 4-(3-Benzyloxy-2-methyl-propoxymethyl)-1,2-dimethoxy-benzene 
• 139017-28-0 1-(3-Benzyloxy-2-methyl-propyl)-1-phenyl-silolane 

Downstream Products

• 63930-49-4 (R)-3-(benzyloxy)-2-methylpropan-1-ol 
• 63930-46-1 (S)-3-benzyloxy-2-methylpropan-1-ol 
• 141885-91-8 (S)-3-benzyloxy-2-methylpropyl acetate 
• 141885-91-8 (R)-3-benzyloxy-2-methylpropyl acetate 
• 96556-45-5 3-(benzyloxy)-2-methylpropyl p-toluenesulfonate 
• 64316-89-8 (S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (R)-3-benzyloxy-2-methyl-propyl ester 
• 64316-89-8 (S)-3,3,3-Trifluoro-2-methoxy-2-phenyl-propionic acid (S)-3-benzyloxy-2-methyl-propyl ester 
• 91273-58-4 3-benzyloxy-2-methyl-1-propyl bromide 
• 1485-70-7 N-benzylbenzamide 
• 4774-58-7 N-benzylisobutyramide 
• 107114-21-6 4-benzyloxy-3-methylbut-1-yne 
• 1612831-49-8 2-(1-(benzyloxy)propan-2-yl)-5-mesityl-6-oxo-3,6-dihydro-2H-pyran-4-yl pivalate 
• 1612831-48-7 6-(1-(benzyloxy)propan-2-yl)-3-mesityldihydro-2H-pyran-2,4-(3H)-dione 
• 1612831-47-6 methyl 7-(benzyloxy)-5-hydroxy-2-mesityl-6-methyl-3-oxoheptanoate 

Relevant articles and documents

6-HETEROARYLOXY BENZIMIDAZOLES AND AZABENZIMIDAZOLES AS JAK2 INHIBITORS

The present disclosure provides 6-heteroaryloxy benzimidazole and azabenzimidazole compounds and compositions thereof useful for inhibiting JAK2.

Substituted heteroaryl compound and composition thereof, and uses of substituted heteroaryl compound and composition thereof

The present invention provides a substituted heteroaryl compound and a composition thereof, and uses of the substituted heteroaryl compound and the composition, wherein the compound is a compound represented by a formula (I) or a stereoisomer, a tautomer, a nitrogen oxide, a solvate, a metabolite, a pharmaceutically acceptable salt or a prodrug of the compound represented by the formula (I). The present invention further provides a pharmaceutical composition containing the compound, wherein the pharmaceutical composition can regulate activity of protein kinases, particularly Aurora kinases and JAK kinases, and can be used for prevention, treatment, therapy and alleviation of protein kinases, particularly Aurora kinases and JAK kinase activity mediated diseases or disorders.

N-SUBSTITUTED PIPERIDINE DERIVATIVES AS SEROTONIN RECEPTOR AGENTS

Disclosed herein are substantially pure forms of the compounds of Formula (I), (II), (III), (IV) and (V), or a pharmaceutically acceptable salt, prodrug, hydrate, solvate, polymorph, stereoisomer or ester thereof. Also disclosed are methods of inhibiting an activity of a serotonin receptor, methods inhibiting an activation of a serotonin receptor, and methods of alleviating or treating various disease conditions and side effects.